| |
| |
|
| Insider
Information: |
Israel Robert J |
| Relationship: |
Executive Vice Preside... |
| City: |
Montebello |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
35,050 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$143,705 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,050 |
|
|
| Total
Value |
$143,705 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Progenics Pharmaceuticals Inc |
PGNX |
Executive Vice Preside... |
2015-06-11 |
35,050 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PGNX |
Progenics Pharmaceuticals... |
Senior VP Medical Affairs |
• – – |
2012-06-01 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
39,383 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior VP Medical Affairs |
• – – |
2012-07-02 |
4 |
OE |
$5.33 |
$5,330 |
D/D |
1,000 |
36,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior VP Medical Affairs |
• – – |
2013-07-18 |
4 |
OE |
$5.33 |
$26,650 |
D/D |
5,000 |
40,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2014-11-11 |
4 |
OE |
$5.03 |
$25,150 |
D/D |
5,000 |
40,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2014-11-13 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
45,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2014-11-21 |
4 |
OE |
$5.35 |
$48,150 |
D/D |
9,000 |
44,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2014-12-11 |
4 |
OE |
$5.35 |
$16,050 |
D/D |
3,000 |
38,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2015-01-12 |
4 |
OE |
$5.33 |
$10,660 |
D/D |
2,000 |
37,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2015-03-03 |
4 |
OE |
$4.70 |
$23,500 |
D/D |
5,000 |
40,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2015-03-11 |
4 |
OE |
$5.33 |
$10,660 |
D/D |
2,000 |
37,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2015-03-13 |
4 |
OE |
$5.35 |
$16,050 |
D/D |
3,000 |
38,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Executive Vice President, Medi |
• – – |
2015-06-11 |
4 |
OE |
$5.33 |
$10,660 |
D/D |
2,000 |
37,050 |
0 |
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Senior Vice President, Medical |
• – – |
2004-12-22 |
4 |
S |
$16.15 |
$82,154 |
D/D |
(5,000) |
14,120 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
SR. VP Medical Affairs |
• – – |
2005-06-20 |
4 |
S |
$19.87 |
$14,903 |
D/D |
(750) |
21,477 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2005-12-19 |
4 |
S |
$22.38 |
$195,843 |
D/D |
(8,750) |
20,496 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
officerTitle |
• – – |
2006-02-01 |
4 |
S |
$27.73 |
$226,646 |
D/D |
(8,142) |
20,628 |
|
- |
|
| PGNX |
Progenics Pharmaceuticals... |
Sr. VP, Medical Affairs |
• – – |
2010-06-22 |
4 |
S |
$5.82 |
$35,961 |
D/D |
(6,180) |
31,186 |
0 |
- |
|
192 Records found
|
|
Page 8 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
